Device
Resolute Onyx
Resolute Onyx is a medical device with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Other(3)
Detailed Status
unknown2
Active, not recruiting1
Suspended1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
active_not_recruiting125%
suspended125%
unknown250%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
NCT04562805
suspended
The Rolex Registry (Revascularization Of LEft Main With Resolute onyX)
NCT03316833
unknown
Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis
NCT03151018
unknownnot_applicable
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
NCT02508714
Clinical Trials (4)
Showing 4 of 4 trials
NCT04562805Not Applicable
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
NCT03316833
The Rolex Registry (Revascularization Of LEft Main With Resolute onyX)
NCT03151018
Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis
NCT02508714Not Applicable
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4